The estimated Net Worth of Aviad Friedman is at least $29 Tausend dollars as of 9 August 2018. Mr. Friedman owns over 2,500 units of Oramed Pharmaceuticals, Inc stock worth over $29,015 and over the last 8 years he sold ORMP stock worth over $0. In addition, he makes $0 as Independent Director at Oramed Pharmaceuticals, Inc.
Aviad has made over 1 trades of the Oramed Pharmaceuticals, Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 2,500 units of ORMP stock worth $12,375 on 9 August 2018.
The largest trade he's ever made was buying 2,500 units of Oramed Pharmaceuticals, Inc stock on 9 August 2018 worth over $12,375. On average, Aviad trades about 500 units every 0 days since 2017. As of 9 August 2018 he still owns at least 12,191 units of Oramed Pharmaceuticals, Inc stock.
You can see the complete history of Mr. Friedman stock trades at the bottom of the page.
Aviad Friedman serves as Independent Director of the Company. Mr. Friedman is an international businessman. Since 2007, he has been Chief Executive Officer of Most Properties 1998 Ltd.. Mr. Friedman was the first Director General of Israel’s Ministry of Diaspora Affairs and served as personal advisor to Prime Minister Ariel Sharon from 1996 to 1999. Mr. Friedman served as Chief Operating Officer of one of Israel’s premier newspapers, Ma’ariv from 2003 to 2007, and has more than 15 years of experience serving on boards of public and private companies including Maayan Ventures, Capital Point, Rosetta Green Ltd and Aerodrome Groupe Ltd. Mr. Friedman additionally served as an investor and consultant at Rhythmia Medical Inc. from 2007, and was actively involved in the sale of the company to Boston Scientific in 2012. Mr. Friedman holds a bachelor’s degree and master’s degree with honors in Public Administration from Bar-Ilan University.
Aviad Friedman is 48, he's been the Independent Director of Oramed Pharmaceuticals, Inc since 2016. There are 10 older and 4 younger executives at Oramed Pharmaceuticals, Inc. The oldest executive at Oramed Pharmaceuticals, Inc is Dr. Miriam Kidron Ph.D., 81, who is the Chief Scientific Officer & Director.
Aviad's mailing address filed with the SEC is 6 HADASSA ST., , TEL AVIV,, L3, 6451306.
Over the last 17 years, insiders at Oramed Pharmaceuticals, Inc have traded over $7,377,390 worth of Oramed Pharmaceuticals, Inc stock and bought 881,642 units worth $3,583,418 . The most active insiders traders include Miriam Kidron, Leonard Sank und Nadav Kidron. On average, Oramed Pharmaceuticals, Inc executives and independent directors trade stock every 111 days with the average trade being worth of $97,149. The most recent stock trade was executed by Arie Mayer on 3 April 2023, trading 8,809 units of ORMP stock currently worth $19,556.
oramed pharmaceuticals (nasdaqcm:ormp) is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. through its patented flagship product, an orally ingestible insulin capsule currently in phase 2 trials under the usfda, the company is seeking to revolutionize the treatment of diabetes. read more: http://www.oramed.com/investors/corporate-presentation watch: https://www.youtube.com/watch?v=5qchxtdv9eg
Oramed Pharmaceuticals, Inc executives and other stock owners filed with the SEC include: